Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - aciclovir -

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline consumer healthcare australia pty ltd - ascorbic acid,biotin,calcium hydrogen phosphate dihydrate,calcium pantothenate,colecalciferol,cyanocobalamin,dl-alpha-tocopheryl acetate,ferrous fumarate,folic acid,heavy magnesium oxide,manganese sulfate monohydrate,nicotinamide,pyridoxine hydrochloride,retinol palmitate,riboflavine,sodium ascorbate,thiamine nitrate,zinc oxide -

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - hepatitis b surface antigen recombinant, quantity: 20 microgram/ml; tetanus toxoid, quantity: 80 iu/ml; pertussis filamentous haemagglutinin, quantity: 50 microgram/ml; poliovirus, quantity: 80 dagu; pertussis toxoid, quantity: 50 microgram/ml; diphtheria toxoid, quantity: 60 iu/ml; pertactin, quantity: 16 microgram/ml; poliovirus, quantity: 16 dagu; poliovirus, quantity: 64 dagu - injection, suspension - excipient ingredients: aluminium phosphate; sodium chloride; aluminium hydroxide hydrate; neomycin sulfate; polymyxin b sulfate; water for injections; glucose monohydrate; polysorbate 80; ascorbic acid; calcium chloride dihydrate; ferric nitrate nonahydrate; potassium chloride; magnesium sulfate heptahydrate; monobasic potassium phosphate; dibasic sodium phosphate; adenine sulfate dihydrate; adenosine triphosphate disodium; adenosine phosphate; cholesterol; deoxyribose; glutathione; guanine hydrochloride monohydrate; sodium hypoxanthine; ribose; sodium acetate; thymine; uracil; sodium xanthine; dl-alanine; arginine hydrochloride; dl-aspartic acid; cysteine hydrochloride; cystine dihydrochloride; dl-glutamic acid; glutamine; glycine; histidine hydrochloride; isoleucine; hydroxyproline; dl-leucine; lysine hydrochloride; dl-methionine; dl-phenylalanine; proline; dl-serine; dl-threonine; dl-tryptophan; tyrosine disodium; dl-valine; biotin; ergocalciferol; calcium pantothenate; choline chloride; folic acid; inosit - infanrix hexa is indicated for primary immunisation of infants from the age of 6 weeks against diphtheria, tetanus, pertussis, hepatitis b, poliomyelitis, and haemophilus influenzae type b. infanrix hexa is also indicated for use as booster dose if boosting with hepatitis b, poliomyelitis, and haemophilus influenzae type b, as well as diphtheria, tetanus and pertussis is required. refer to dosage and administration for further information.

Australia - English - Department of Health (Therapeutic Goods Administration)

glaxosmithkline australia pty ltd - aciclovir -

New Zealand - English - Medsafe (Medicines Safety Authority)

glaxosmithkline nz limited - hydrocortisone 1% - topical cream - 1 % - active: hydrocortisone 1%

Malta - English - Medicines Authority

glaxosmithkline consumer health-care uk trading limited 980 great west road, brentford, middlesex, tw8 9gs, united kingdom - ropinirole - film-coated tablet - ropinirole 0.25 mg - anti-parkinson drugs

Malta - English - Medicines Authority

glaxosmithkline consumer health-care uk trading limited 980 great west road, brentford, middlesex, tw8 9gs, united kingdom - ropinirole - film-coated tablet - ropinirole 0.5 mg - anti-parkinson drugs

Malta - English - Medicines Authority

glaxosmithkline consumer health-care uk trading limited 980 great west road, brentford, middlesex, tw8 9gs, united kingdom - ropinirole - film-coated tablet - ropinirole 2 mg - anti-parkinson drugs

Malta - English - Medicines Authority

glaxo smithkline uk limited - dutasteride - soft capsule - dutasteride 0.5 mg - urologicals

Malta - English - Medicines Authority

glaxo smithkline uk limited - dutasteride; tamsulosin hydrochloride - hard capsule - dutasteride 0.5 mg; tamsulosin hydrochloride 0.4 mg - urologicals